Clinical Case Series Evaluating Skin Wellness System
NCT01724229 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2013-06-25
Summary
The purpose of this evaluation is to observe the performance of two (2) different skin care treatment protocols on the skin:
#1 Kendall™ Body Wash \& Shampoo in combination with the Moisture Barrier Cream; or #2 Kendall™ 2-in-1 Cleanser in combination with the Anti-fungal Cream.
The scientific evidence supports using these types of skin care products to keep the skin healthy in the presence of moisture, urine, stool, or fungal infection. The cleansers are preferred over soap and water and can be applied on all areas of the skin. The Moisture Barrier Cream is formulated especially for skin exposed to moisture, urine, or stool. The Antifungal Cream is utilized for fungal infections associated with athlete's foot, jock itch, and ring worm to relieve itching, soreness, and irritation.
Conditions
- Moisture-associated Dermatitis
- Fungal Infection in Perineal Area
Interventions
- DRUG
-
Kendall Body Wash & Shampoo; Moisture Barrier Cream; 2-in-1 Cleanser; Antifungal Cream
Sponsors & Collaborators
-
GM Associates
lead INDUSTRY
Principal Investigators
-
Glenda J Motta, BSN, MPH, ET · GM Associates Inc.
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis
NCT02546258 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
NCT02582177 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
NCT01473316 ·Status: COMPLETED ·Phase: PHASE1
-
Micro-Technique Sampling
NCT03242577 ·Status: COMPLETED
-
Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
NCT02933879 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
NCT05597462 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)
NCT00869336 ·Status: COMPLETED ·Phase: PHASE2
-
Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
NCT01203189 ·Status: COMPLETED ·Phase: NA
-
Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers
NCT01690286 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118
NCT01520896 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
NCT02842021 ·Status: TERMINATED ·Phase: PHASE2
-
Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years
NCT01696799 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of The Effects of Multiple Doses of Ketoconazole on Single Dose Pharmacokinetics of RO4602522 in Healthy Male Volunteers
NCT01625806 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Systemic Absorption of MOB015B
NCT03244280 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections
NCT01102387 ·Status: COMPLETED ·Phase: PHASE2
-
Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
NCT03216200 ·Status: COMPLETED ·Phase: NA
-
Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812
NCT00411866 ·Status: COMPLETED ·Phase: PHASE1
-
Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study
NCT04341402 ·Status: UNKNOWN ·Phase: PHASE2
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
NCT00680160 ·Status: COMPLETED ·Phase: PHASE2
-
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
NCT00602342 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis
NCT01431820 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
NCT00443898 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis
NCT03824912 ·Status: COMPLETED ·Phase: PHASE3
-
The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial
NCT04007237 ·Status: COMPLETED ·Phase: PHASE4
-
Terbinafine HCl 250 mg Tablet Under Fasting Conditions
NCT00833586 ·Status: COMPLETED ·Phase: PHASE1